RePORT International Resources

In-person courses and virtual options, too - Free online courses We currently offer the following online courses, free of charge: How to develop a research grant proposal (English) Interpretation of CXR in children with presumptive TB (English) Interpretation of CXR in adults (French) Prevent TB: management of TB infection (English, French and Spanish)

You must first log in to the Union site to access these courses.

The app still offers the same comprehensive range of courses from The Union, equipping you and your team with the skills to effectively treat and manage tuberculosis – using the latest insights from leading experts around the world.

The Union has three official journals: >> The International Journal of Tuberculosis and Lung Disease, IJTLD - the leading peer-reviewed journal dedicated to lung health worldwide. >> IJTLD Open - The Union's new Open Access journal for the latest research on TB and lung diseases including asthma, COVID-19 and COPD. >> Public Health Action - the latest operational research on health systems.

This online course from The Union will provide researchers with the relevant knowledge and skills to be able to plan, design, and write grants in their own right. It is available to all audiences as an asynchronous online learning option with a mix of educational units of about 20 min each. A variety of engaging activities such as polls, quizzes, small case studies, multiple-choice questions are used to support learner engagement.

The Union is submissions for Abstracts, Symposia, Satellite Sessions, and Post-Graduate Courses and Workshops for the World Conference on Lung Health 2025. The deadline is 9 April (except for Satellite Sessions where submissions end on 30 May). Please review the Key Dates to help you plan and keep in mind all Conference-related information for the year.

This webinar recording explores mycobacterial diagnostic tools and their applications in TB prevention and treatment. Learn to effectively use and interpret TSTs, IGRAs, and cultures for diagnosing LTBI and active TB disease. Case studies will highlight real-world challenges and best practices for leveraging these tools in clinical practice.

The purpose of this program is to encourage the development of researchers in child health by awarding small grants to new researchers, helping them gain a foothold in this important area. The goal is to fund applicants who will go on to be independent investigators. The Fund will make up to 32 awards total with two funding cycles (16 awards each).

TB in pregnancy poses serious risks to both mother and fetus if not promptly diagnosed and managed. This webinar recirding covers key aspects of TB diagnosis, treatment, and complications during pregnancy. Participants will also be introduced to the TB Pregnancy Toolkit and other resources to support effective care for pregnant patients.

The purpose of this notice of funding opportunity (NOFO) is to support the establishment of multidisciplinary Tuberculosis (TB) Research Units (TBRUs) that will operate as a collaborative network to improve understanding of Mycobacterium tuberculosis (Mtb)-host interactions through characterizing the roles of bacterial and host heterogeneity on infection outcomes and disease progression, and defining bacterial and host determinants relevant to Mtb establishment, dissemination, and disease stage. Please refer to the website for detail announcement and key dates.

University of California San Francisco (UCSF) Center for Tuberculosis offers education, training, research support, and program development resources for healthcare professionals and public health providers. Please explore the website for more details.

This is an archived collection of past webinars from the UCSF Curry International TB Center. Recordings and materials are available for reference and continued learning for researchers and clinicians.

A free educational tool for healthcare providers treating pediatric TB. Updated in May 2025, it includes a five-part video series (64 minutes) by Dr. Ann M. Loeffler and downloadable clinical tools and handouts.

This 3-session webinar series highlight lectures from The Union-North American Region (NAR) 2025 Annual TB Conference. This webinar includes 1. The Riddle of TB Drug Resistance, 2. What is Hot in Treatment Differentiation and Individualization and 3. Reframing Directly Observed Treatment.

The UCSF Curry International TB Center offers free training opportunities for healthcare and public health professionals involved in TB prevention and care. Core trainings cover key topics such as case management, contact investigation, LTBI, clinical care, and program management, and are available in both hybrid and in-person formats. All trainings are free of charge, but registration and application are required. For further questions, please contact: CurryTBCenter@ucsf.edu.

Offers funding and support across all academic disciplines and industrial areas from the medical and biological sciences to astronomy, physics, chemistry and engineering, social sciences, economics, environmental sciences, and the arts and humanities.

To address the need for trustworthy and scientifically based information focused on providing a basic understanding of science, HANC responded by creating an ad-hoc work group with international membership to develop videos on several important topics. On this page you will find videos and links to additional resources that aim to make understanding science and clinical research easier. Videos include: Why is Science Essential?, Why is Research Important in Science?, Who are Clinical Research Stakeholders?, The Scientific Method, and Regulations and Clinical Research Studies.

This webinar covered Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in persons with TB and how to medically manage these patients.

The world's largest lung health conference, the World Conference on Lung Health, will take place at the Bella Center in Copenhagen, Denmark from 18-21 November 2025.

Unitaid supports in making new health products available and affordable for people in low- and middle-income countries. It identifies innovative treatments, tests and tools, help tackle the market barriers that are holding them back, and get them to the people who need them most – fast. It provides health partners with financial grants to accelerate innovation in global health.